ABSTRACT
The inositides are key cellular second messengers with well established roles in signal transduction pathways initiated by cell surface receptor activation. The recent identification of an evolutionarily conserved nuclear signaling pathway for higher inositol polyphosphates has defined a new signaling paradigm for this diverse class of molecules whose biosynthesis and regulation is mediated by what are likely some of the earliest ancestors of the inositide kinase families.
Inositol polyphosphate multikinase (IPMK) represents the most catalytically diverse member of this family with critical roles in nuclear functions including mRNA export, transcriptional regulation, and chromatin remodeling.
INTRODUCTION
The inositides define a large family of lipid and water-soluble metabolic and messenger molecules with roles in diverse cellular processes (1-3).
Inositide biosynthesis occurs through the modification of the sugarlike, six-carbon ring of myo-inositol (Figure 1 ). Combinatorial phosphorylation of inositides results in more than 30 different inositol phosphates and seven phosphoinositides-lipid inositols, also termed phosphatidylinositol (PtdIns or PI) phosphates, comprised of diacylglycerol (DAG) and inositol phosphates. Signaling roles for inositides were first suggested by studies of receptor-stimulated phosphoinositide metabolism (4) , but the first definitive assignment of physiologic functions for inositides came with the identification of the now well known role of inositol 1,4,5-trisphosphate (Ins(1,4,5)P 3 ) as the calcium releasing factor generated upon cell surface receptor activation (5) .
In what has become a classic formulation of receptor-mediated cell signaling, ligand activation of receptor tyrosine kinases or G-protein coupled receptors results in the cellular accumulation of Ins(1,4,5)P 3 and DAG via hydrolysis of the membrane bound lipid inositol, PtdIns(4,5)P 2 , by phosphoinositide-specific phospholipase C (PLC) (6) . DAG goes on to activate protein kinase C (PKC) (7) while Ins(1,4,5)P 3 binds the Ins(1,4,5)P 3 -receptor/channel and allosterically mediates the release of Ca 2+ from intracellular pools within the endoplasmic reticulum (5, 8, 9) . Within a short span of years following the characterization of the PLC-initiated "inositol cycle" and second-messenger roles for Ins(1,4,5)P 3, inositide metabolism experienced a dramatic expansion initiated by the identification of more phosphorylated D3 derivatives of lipid and water-soluble inositol phosphates (10-13).
Inositol polyphosphates' entrance into the limelight of cell signaling in the mid to late 1980's with the discovery of Ins(1,4,5)P 3 and its second messenger role in calcium mobilization was followed by a decade or more of research dominated by the phosphoinositide lipids. To a large degree this was the result of the identification of PtdIns(3,4,5)P 3 as a constituent of phosphoinositides extracted from activated neutrophils (12) and the isolation of a phophoinositide-3 kinase (PI3K) activity associated with viral Src and the middle-T antigen of the polyoma virus (13)-discoveries that recast the lipid inositols as signaling molecules in their own right independent of their precursor roles for Ins(1,4,5)P 3 . This was followed by the characterization of important signaling roles for PI3K in cell migration, growth, proliferation, and survival as well as the identification of lipid inositol receptors and binding domains (14) . During this period, while additional watersoluble inositols were identified, the functional significance of "higher" inositol metabolism, the delineation of inositol polyphosphate receptors, and/or the identification of enzymes involved in their metabolism lagged behind. However, the recent cloning and characterization of the kinases responsible for higher inositol polyphosphate synthesis has shed new light on the diverse and complex water-soluble domain of the inositides. In particular, the identification of an evolutionarily conserved, ancient inositol polyphosphate kinase family and its roles in nuclear inositide metabolism has served to expand our understanding of the biological significance of the inositides beyond classical conceptions of their plasma membrane and cytoplasmic signaling roles. In this review, we shall limit our focus to the most catalytically flexible member of this family and its roles in nuclear functions, the inositol polyphosphate multikinase (IPMK).
DISCOVERY AND BIOCHEMICAL CHARACTERIZATION
The discovery of D3-hydroxyl phosphorylation of Ins(1,4,5)P 3 was followed by the identification of the ubiquitous prevalence of additional more phosphorylatedand in fact the most abundant-eukaryotic inositol polyphosphates, InsP 5 and InsP 6 (15) . Full combinatorial phosphorylation of the inositol ring suggested an upper limit of 63 discrete inositol phosphates with the fully phosphorylated InsP 6 as the metabolic endpoint of sequential phosphorylation of Ins(1,4,5)P 3 . However, the identification of pyrophosphate (diphosphate) inositol species with seven and eight phosphates revealed an expanded potential for the inositol ring (16, 17 
Remarkably, the other family members identified included the Ca 2+ -sensitive Ins(1,4,5)P 3 3-kinases first identified to mediate D3-hydroxyl phosphorylation of Ins(1,4,5)P 3 and Arg82 (also known as ArgRIII), a predominantly nuclear, Saccharomyces cerevisiae yeast protein previously characterized as an arginine-sensitive transcription factor (20, 21) .
Incubation of InsP 3 with purified Arg82 revealed it to be an inositol kinase with the ability to generate a series of higher inositol polyphosphates ( Figure 1 Ins ( Table 1 ). Like the yeast enzyme, mammalian, plant, and fly orthologs share the capacity for the conversion of Ins(1,4,5)P 3 to Ins(1,3,4,5,6)P 5 . However, while plant and fly IPMKs recapitulate the yeast enzyme's preference for D6-hydroxyl phosphorylation followed by D3-hydroxyl phosphorylation (33, 34) , mammalian IPMKs appear to prefer the reverse order (25, 37). The evolutionary conservation of IPMK's InsP 3 /InsP 4 dualspecificity 6-/3-kinase activities suggests the sequential metabolism of Ins(1,4,5)P 3 to InsP 6 first observed in yeast is likely retained across species. Indeed, the rat, plant, and fly enzymes can rescue the inositol metabolism defects observed in ipmk mutant yeast confirming the in vivo relevance of these activities (33, 34, 36, 38, 39) . The 3-step pathway to InsP 6 mediated by Plc1, Ipmk, and Ipk1 contrasts with alternative descriptions of a 5-step pathway proposed to occur in human cells. This latter metabolic pathway can be summarized as follows: PtdIns(4,5)P 2 Ins(1,4,5)P 
NUCLEAR FUNCTIONS

Arginine-dependent transcription in yeast
Though canonical cytoplasmic and plasma membrane functionalities dominate second messenger signaling dogmas for inositide metabolism, signaling roles for nuclear inositides were identified very shortly after the initial characterization of the "inositol cycle" and its role in receptor-mediated Ca 2+ signaling (48) . The functional importance of a separable, nuclear phosphoinositide metabolic pool was suggested by early observations in animal cells of IGF-1-induced decreases in nuclear Figure 1 . Myo-inositol and the multiple water-soluble kinase activities of IPMK. Myo-inositol is a 6-carbon cyclitol defined by five equatorial hydroxyls and a single D2 axial hydroxyl. While most characterized IPMK products are the result of D3, D5, or D6 phosphorylation of the inositol ring additional D1-kinase and pyrophosphate synthase activities have also been described.
PtdIns4P and PtdIns(4,5)P 2 accompanied by the production of nuclear DAG and the nuclear translocation of PKC (49, 50) .
Further studies provided evidence for nuclear functions in cell cycle control and the regulation of nuclearenvelope breakdown prompting the forward-thinking proposal that the nucleus may have been the original site of inositide evolution (51) . Nonetheless, the functional significance of nuclear inositide metabolism remained obscure and unappreciated. The identification of IPMK, a nuclear "transcription factor," as the first step in an evolutionarily conserved pathway for inositol metabolism required for mRNA export confirmed the inositides' potential preeminence in nuclear functions.
The characterization of IPMK's inositol kinase activity came after nearly two decades of research had clearly identified the yeast protein (originally named ArgRIII, then subsequently Arg82) as a necessary component of arginine-dependent transcriptional regulation (20, 21, 52) (Figure 2 ). Yeast are particularly attuned to the nutritional availability of amino acids and nitrogen sources, transcriptionally regulating catabolic and anabolic metabolism in response to environmental changes (21) . IPMK along with ARG80, ARG81, and MCM1 were originally identified in a screen for yeast mutants unable to grow on agar with non-preferred arginine/ornithine as the sole nitrogen source (21) . Subsequent studies defined the four gene products as comprising an ArgR/Mcm1 transcriptional complex regulating the suppression of arginine anabolic genes (ARG1, ARG3, ARG5,6 and ARG8) and the induction of catabolic genes (CAR1 and CAR2) in response to the availability of arginine or optimal nitrogen sources in the environment (53) (Figure 2 ).
The first investigations examining whether Ipmk's regulatory role in ArgR/Mcm1-dependent functions involves its enzyme activities indicated that argininesensitive transcriptional responses did indeed require Ipmk's inositol polyphosphate kinase activities (24). This conclusion was mainly derived from experiments demonstrating the inability of kinase-dead Ipmk to rescue growth defects of ipmk-deficient yeast on agar containing arginine/ornithine as the sole nitrogen source. Furthermore, a similar growth phenotype was observed in plc1-deficient yeast but not in ipk1 mutant yeast, suggesting a specific role for either InsP 4 or InsP 5 in transcriptional regulation (24). In the same study, a kinaseindependent role was suggested in the pre-activation assembly of the ArgR/Mcm1 complex on DNA promoter elements (24). However, a subsequent study by Dubois and colleagues challenged the kinase-dependent roles attributed to Ipmk in transcriptional regulation as this group failed to replicate the growth defects of plc1 mutant yeast (54) . More recent studies by Snyder and associates examined arginine-dependent mRNA transcript regulation directly in lieu of growth phenotype analyses and offered an alternative interpretation for Ipmk's functionality in transcriptional regulation based on the identification of Ipmk as an inositide lipid kinase (47).
IPMK is a nuclear PI3K
The surprise addition of a phosphoinositide kinase activity to IPMK's growing list of water-soluble inositol kinase activities was the result of in vitro experiments in which brain lipid extracts were incubated with the kinase. The production of a single product identified as PtdIns(3,4,5)P 3 revealed IPMK to be a non- canonical PI3K (Figure 3 ). Yeast and rat IPMKs display similar kinetic parameters to those previously observed for the canonical PI3Ks but greater substrate specificity as only PtdIns(4,5)P 2 appears to serve as a substrate in contrast to the multiple in vitro activities observed for canonical PI3Ks. IPMK PI3K activity is further distinguished from previously characterized PI3Ks in its complete insensitivity to pharmacological inhibition by wortmannin, a potent inhibitor of canonical PI3Ks. Overexpression studies in mammalian cells demonstrated IPMK's ability to dramatically increase nuclear PtdIns(3,4,5)P 3 concentrations suggesting a physiologic relevance for the activity (47).
The discovery of Ipmk's PI3K activity prompted the Snyder group to reevaluate the enzyme's role in arginine-dependent transcription.
Monitoring ARG8 mRNA, normally suppressed in the presence of arginine, they observed derepression and constitutive elevated levels of the transcript in ipmk mutant yeast but not in ipk1-or ip6k-deficient yeast confirming the requirement for Ipmk in the transcriptional regulation of arginine anabolism. A further necessity for kinase activity in ARG8 regulation was evidenced by the inability of a kinase-dead mutant to restore wild-type suppression of ARG8 in ipmk mutant yeast. However, examination of ARG8 in plc1-deficient yeast, which entirely lack Ins(1,4,5)P 3 and the more phosphorylated higher inositol polyphosphates, revealed wild-type levels of ARG8 thus implicating Ipmk's lipid kinase activity in ArgR/Mcm1 transcriptional complex regulation (47) . The re-appearance of elevated levels of ARG8 mRNA in a plc1/ipmk double knockout confirmed the proposed role for Ipmk's PI3K activity in argininedependent transcription. While the mechanism of action of Ipmk's role in ArgR/Mcm1-dependent functions in response to arginine remains to be fully elucidated, more recent studies suggest Ipmk's kinase activities control gene expression in yeast in response to a larger set of environmental and nutritional signals as part of a more general role for nuclear inositol polyphosphate metabolism in transcriptional regulation (55) (56) (57) (Figure 4 ).
Phosphoinositide 3-kinase related protein kinase regulation
Regulation of arginine catabolism by the ArgR/Mcm1 complex in yeast in response to nitrogen availability is part of a larger catabolic control response mediated by a process termed nitrogen catabolite repression (NCR) in which the absence of preferred nitrogen sources such as ammonia, asparagine, or glutamine results in the transcriptionally initiated catabolism of alternative nitrogen sources (58) . DNA microarray analyses of ipmk mutant yeast suggest an essential role for Ipmk and its catalytic products in mediating the NCR response beyond arginine metabolism with a large subset of NCR-required genes displaying altered expression (57) . Pharmacological (58, 60) . TOR kinases belong to a class of phosphoinositide 3-kinase related protein kinases (PIKKs) with roles in cell growth, gene expression, and genome surveillance and repair (61) . Intriguingly, in recent years a theme of nuclear inositol polyphosphate regulation of PIKKs has begun to emerge. In yeast, Ipmk was identified as a dosage suppressor of mec1, a PIKK yeast homologue of the mammalian ataxia-telangiectasia mutant (ATM) with functional roles in DNA damage response (62) . More recently two independent studies identified a role for inositol pyrophosphates in the regulation of telomere length mediated by Tel1, a second PIKK yeast homolog of ATM (63, 64) . Lastly, a role for inositol polyphosphates in PIKK-mediated nonhomologous end joining (NHEJ) has been proposed by experiments demonstrating InsP 6 regulation of the exclusively metazoan DNA-dependent protein kinase (DNA-PK) (65, 66).
Chromatin remodeling
Recently, work from the O'Shea laboratory has expanded IPMK's role in nutrient sensing to phosphatelimitation response programs (56) . In a genetic screen for yeast mutants defective in phosphate-responsive signal transduction pathway elements, O'Shea and colleagues identified ipmk mutant yeast as defective in the induction of the phosphate-responsive PHO5 gene. Additional characterization revealed that expression of Pho5 was repressed in the IPMK mutant strain as a result of the failure of chromatin remodeling complexes to mobilize nucleosomes from the promoter, thus preventing access for regulatory factors and machinery necessary for transcription (56) . A similar phenotype was observed in plc1-deficient strains but not in yeast strains lacking InsP 6 suggesting a selective role for InsP 4 and InsP 5 in the regulation of chromatin remodeling (56) .
In vitro nucleosome mobilization assays by Wu and co-workers proposed direct targeting of the chromatin remodeling complex by inositol polyphosphates (55) though the use of non-physiologic concentrations of inositides in these studies suggests further characterization of the process is necessary (67) . Subsequent studies revealed that in addition to InsP 4 and InsP 5, the inositol pyrophosphates likely also play a role in the phosphate-responsive signal transduction pathway suggesting Ipmk's role in transcription may occur at multiple levels, with both direct and precursor roles for its catalytic products (68-70) (Figure 4 ).
Metazoan nuclear roles
While the genetic tractability of the budding yeast has afforded significant insights into the functional roles of Ipmk and its catalytic products (Figure 4) , whether or not its roles in transcriptional regulation, chromatin remodeling, and mRNA export are conserved in metazoans and higher species remains to be fully elucidated. Examinations of plants deficient in IPMK suggest roles in pollen germination, root growth, as well axillary shoot branching (71, 72) .
A recent genome-wide RNA interference (RNAi) screen in cultured Drosophila melanogaster haemocyte-like cells identified IPMK as a regulator of the Janus tyrosine kinase/signal transducer and activator of transcription (JAK/STAT) pathway, though the mechanism for this interaction remains undescribed (73) . Studies of human cells provide support for a role for inositol polyphosphates in mRNA export as cells expressing the virulence factor SopB, an inositol phosphatase capable of inositol polyphosphate depletion, accumulate mRNA in the nucleus (74) . The recent characterization of IPMK knockout mice demonstrates critical roles for IPMK in embryogenesis and central nervous system development (75) . Deletion of IPMK in mice results in early lethality with few embryos surviving beyond E8.5. Embryos exhibit a number of abnormal developmental phenotypes including abnormal neural tube folding, failure to turn, a delay and reduction in somite formation, elongation of the anterior/posterior axis, and an absence of allantois and chorion fusion (75) . Transcriptional regulatory defects may indeed underlie many of these developmental phenotypes though a role for sequential metabolism mediated by IPK1 and IP6K cannot be excluded. Indeed, deletion of IPK1 also results in early embryonic lethality in mice suggesting a required role for InsP 6 and/or the inositol pyrophosphates in mammalian development (76) .
Though little is known of the physiologic significance of IPMK in mammals beyond the initial characterization of the conventional knockout mouse, the generation of conditional knockout mice bypassing embryonic lethality will likely provide additional inroads to the functional significance of IPMK and downstream metabolites in mammalian biology.
PERSPECTIVE
The recent discovery of PtdIns(3,4,5)P 3 in fission yeast confirms the early evolutionary emergence of the lipid inositol (77) . As yeast do not possess a canonical PI3K homolog capable of PtdIns(3,4,5)P 3 synthesis, the identification of yeast Ipmk as a nuclear PI3K suggests IPMK may represent the earliest incarnation of a lipid inositol kinase capable of D3 phosphorylation of PtdIns(4,5)P 2 .
Structure database comparisons of the recently solved crystal structures of Ins(1,4,5)P 3 3-kinase and yeast Ipmk confirm the enzymes' close structural relationship to the lipid inositol kinases despite little primary amino acid sequence similarities (78) (79) (80) . It also follows that the emergence of PtdIns(3,4,5)P 3 functionality in the nucleus may have preceded its cytoplasmic roles associated with the advent of canonical PI3K signaling at the plasma membrane. It is worth noting that nuclear lipids are not restricted to the nuclear membrane and exist in detergent-resistant, yet unidentified components of the nuclear interior (81, 82) .
Consistent with Ipmk's phosphoinositide-dependent functionality in transcriptional regulation in yeast, studies in mammals have suggested roles for nuclear inositol lipids in the regulation of the BAF chromatin remodeling complex (83) . The identification of chromatin-associated proteins as nuclear phosphoinositide receptors lends further support for the role of nuclear inositol lipids in modulating chromatin structure (84) . How IPMK's promiscuous lipid and watersoluble kinase activities are individually regulated remains unknown though in vivo phosphorylation of the enzyme has been observed (A.C.R., unpublished observations) suggesting posttranslational modification may regulate these activities. Furthermore, while emphasis is often placed on the InsP 4 and InsP 5 catalytic products of IPMK, potential roles for its other less characterized products and specifically its pyrophosphate synthase activities should not be ruled out. What "upstream" cell signals impinge on IPMK functionality also remains uncharacterized. In mammalian tissues, components of the canonical PI3K signaling pathway exist in nuclei and nuclear translocation and regulation of canonical PI3K in response to cell surface receptor activation has also been described (82, (85) (86) (87) . One of the best described downstream targets of canonical PI3Ks is Akt, a serine-threonine kinase with a central role in cancer pathology and regulation of cell survival (88) . While much of the functional characterization of Akt has focused on its cytoplasmic roles, additional studies have highlighted roles for its nuclear localization.
Once activated in the cytoplasm, Akt translocates to the nucleus where it phosphorylates additional substrates including the FoxO family of transcription factors (89) . Recent data from a number of model systems suggest nuclear PI3K/Akt may in fact play integral roles in the regulation of tumorigenesis and apoptosis protection complementing their cytoplasmic functionality, though additional work is necessary to characterize these processes (86) . Whether the activities of the canonical PI3K and IPMK function in concert or independently in the regulation of nuclear events is still unclear.
Intriguingly, a recent RNAi-based screening of the human kinome identified IPMK as an Aktcooperating kinase whose knockdown enhanced the efficacy of Akt-directed inhibitors suggesting the targeting of IPMK may hold future therapeutic promise for the treatment of cancer (90).
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